Compositions and methods for assessing cytotoxicity of single cells

Details for Australian Patent Application No. 2009338127 (hide)

Owner The General Hospital Corporation d/b/a Massachusetts General Hospital Massachusetts Institute of Technology

Inventors Love, John Christopher; Varadarajan, Navin; Julg, Boris; Walker, Bruce

Agent Cullens

Pub. Number AU-A-2009338127

PCT Pub. Number WO2010/085275

Priority 61/146,106 21.01.09 US

Filing date 13 July 2009

Wipo publication date 29 July 2010

International Classifications

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

G01N 33/52 (2006.01) Investigating or analysing materials by specific methods not covered by groups -

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/563 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving antibody fragments

Event Publications

28 July 2011 PCT application entered the National Phase

  PCT publication WO2010/085275 Priority application(s): WO2010/085275

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009338132-Extrusion bonded laminates for absorbent articles

2009338124-CAES plant using humidified air in the bottoming cycle expander